DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
This Quarter Return
+14.02%
1 Year Return
-10.85%
3 Year Return
+35.19%
5 Year Return
+71.7%
10 Year Return
–
AUM
$1.4B
AUM Growth
+$1.4B
(+13%)
Cap. Flow
+$8.54M
Cap. Flow
% of AUM
0.61%
Top 10 Holdings %
Top 10 Hldgs %
25.79%
Holding
334
New
27
Increased
122
Reduced
148
Closed
6
Top Buys
| 1 |
Vanguard Total World Stock ETF
VT
|
$2.55M |
| 2 |
Vanguard Emerging Markets Government Bond ETF
VWOB
|
$2.19M |
| 3 |
Vanguard Energy ETF
VDE
|
$1.73M |
| 4 |
Microsoft
MSFT
|
$1.22M |
| 5 |
Home Depot
HD
|
$1.21M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
$5.66M |
| 2 |
iShares Micro-Cap ETF
IWC
|
$4.83M |
| 3 |
Vanguard Small-Cap ETF
VB
|
$1.69M |
| 4 |
Reliance Steel & Aluminium
RS
|
$1.12M |
| 5 |
MZTI
The Marzetti Company Common Stock
MZTI
|
$1.05M |
Sector Composition
| 1 | Technology | 17.34% |
| 2 | Healthcare | 12.26% |
| 3 | Financials | 10.7% |
| 4 | Consumer Staples | 9.66% |
| 5 | Consumer Discretionary | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PANA.WS
326
DELISTED
Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class
PANA.WS
| $35K | ﹤0.01% |
11,063
| – | – |
|
|
RGLS
327
DELISTED
Regulus Therapeutics
RGLS
| $16K | ﹤0.01% |
1,200
| – | – |
|
|
BMY.RT
328
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $14K | ﹤0.01% |
20,239
-5,740
| -22% | -$3.97K |
|
329
Schrodinger
SDGR
$1.42B
| – | – |
-9,828
| Closed | -$467K |
|
330
Viasat
VSAT
$3.96B
| – | – |
-8,175
| Closed | -$281K |
|
331
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$264M
| – | – |
-180
| Closed | -$286K |
|
|
WORK
332
DELISTED
Slack Technologies, Inc.
WORK
| – | – |
-15,470
| Closed | -$416K |
|
|
YELL
333
DELISTED
Yellow Corporation Common Stock
YELL
| – | – |
-10,000
| Closed | -$39K |
|
334
S&P Global
SPGI
$165B
| – | – |
-595
| Closed | -$215K |
|